Cannara Biotech Inc. To Participate At Canaccord Genuity’s 7th Annual Global Cannabis Conference
MONTREAL, May 11, 2023 /PRNewswire/ – Cannara Biotech Inc. (“Cannara” or the “Company“) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced its upcoming participation at Canaccord Genuity’s 7th annual global cannabis conference. This one-day event will feature company presentations and one-on-one meetings with senior management teams representing the most reputable and recognizable names in the thriving cannabis industry.
Related news for (LOVFF)
- Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates
- Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025
- Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors
- Cannara Biotech to Present at The Ventum Canadian Cannabis Conference on March 12th, 2025
- Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025